Patents by Inventor Robert Gene Franz

Robert Gene Franz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Endothelin receptor antagonists
    Patent number: 5929106
    Abstract: Dihydroisoindole compounds of formula (I), wherein the substituents are as defined herein, are disclosed as being useful as endothelin receptor antagonists. The compounds are applied in the treatment of cardiovascular and renal diseases.
    Type: Grant
    Filed: October 27, 1997
    Date of Patent: July 27, 1999
    Assignee: SmithKline Beecham Corporation
    Inventors: John Duncan Elliott, Robert Gene Franz, M. Amparo Lago, Aiming Gao
  • Endothelin receptor antagonists
    Patent number: 5736564
    Abstract: The present invention relates to dihydroisoindole compounds, pharmaceutical compositions containing these compounds, and their use as endothelin receptor antagonists.
    Type: Grant
    Filed: December 12, 1996
    Date of Patent: April 7, 1998
    Assignee: SmithKline Beecham Corporation
    Inventors: John Duncan Elliott, Robert Gene Franz, M. Amparo Lago, Aiming Gao